# Day 30: Milestone 06-05: Multi-Role E2E Closed-Loop Verification & Week 6 Close

**Date:** October 15, 2026  
**Milestone:** 06-05 (Week 6 Final Close)  
**Primary Commits:**  
- `9605159: feat(testing): implement week 6 multi-role e2e clinical closed loop test suite`  
- `ff2e865: feat(frontend): integrate cds warning banners and pharmacy dispense modal`  

---

## 1. Objectives & Sprint Scope

Day 30 completes **Week 6: Electronic Prescriptions, Medication Catalog & Pharmacy Dispense Engine**, finalizing the second half of Month 2. Following the delivery of the Medication Catalog (Day 26), e-Prescription Authoring Pad (Day 27), Clinical Decision Support (CDS) Safety Engine (Day 28), and Pharmacy Dispense Lifecycle (Day 29), Day 30 engineered the **Multi-Role End-to-End Closed-Loop Verification Suite** and Cal.com-inspired clinical user interface components.

The core engineering objectives were:
1. **Multi-Role Closed-Loop Verification Suite:** Develop an integration test suite (`backend/tests/test_week_6_e2e_verification.py`) exercising the entire outpatient medication lifecycle across 4 distinct clinical personas (Prescribing Physician, Patient with ABHA, Dispensing Pharmacist, and Unauthorized Tenant).
2. **Clinical Decision Support (CDS) Surveillance Verification:** Verify rule-based safety interception across Drug-Drug Interactions (DDI), Drug-Allergy cross-reactivity, and Drug-Condition contraindications.
3. **Cryptographic Integrity & Immutability:** Verify SHA-256 digital signature seals and strict post-signature immutability guardrails (HTTP 409 Conflict).
4. **Pharmacy Fulfillment & Refill Quota Enforcement:** Validate original fills, generic substitution governance, automatic prescription completion upon repeat exhaustion, and rejection of unauthorized excess refills (HTTP 400 REFILLS_EXHAUSTED).
5. **HL7 FHIR Release 4 & ABDM NRCeS Conformance:** Verify canonical export for `MedicationRequest` and `MedicationDispense` resources.
6. **Cal.com-Inspired UI Components:** Engineer `CDSAlertBanner.tsx` and `PharmacyDispenseModal.tsx`, integrating real-time safety surveillance and pharmacy fulfillment into the clinician authoring workflow.
7. **Production Verification & Alpha Release Preparation:** Run full automated backend pytest suites (228 tests) and Next.js production builds.

---

## 2. Engineering Work Completed

### Multi-Role Closed-Loop Test Suite (`backend/tests/test_week_6_e2e_verification.py`)
- Authored a comprehensive 882-line asynchronous integration test suite testing the complete clinical medication workflow:
  1. **Provisioning Multi-Role Personas:**
     - Prescribing Physician: Dr. Arvind Saxena (Cardiologist, Delhi Medical Council registration, HPR ID).
     - Primary Patient: Vikram Singhania (ABHA ID `91-4455-6677-8899`, blood group O+).
     - Dispensing Pharmacist / Practitioner: Meera Nair (Clinical practitioner with dispensing credentials).
     - Unauthorized Tenant Patient: Priya Sharma (Testing cross-tenant data privacy).
  2. **Longitudinal Clinical Problem Profiling:**
     - Patient profile seeded with "Chronic Kidney Disease Stage 3" (ICD-10 `N18.3`, SNOMED-CT `433144002`).
     - Supplemental hypersensitivity: "Severe penicillin anaphylaxis".
  3. **Pre-Prescription CDS Safety Surveillance:**
     - **Condition Contraindication Interception:** Candidate NSAID (Ketorolac 10mg) evaluated against active CKD Stage 3 diagnosis $\rightarrow$ intercepts `CRITICAL` alert ("Acute Renal Decompensation: NSAID in Chronic Kidney Disease"), blocking issuance without clinical override.
     - **Allergy Cross-Reactivity Interception:** Candidate penicillin antibiotic (Amoxicillin 500mg) evaluated against documented penicillin allergy $\rightarrow$ intercepts `CRITICAL` alert ("Penicillin Hypersensitivity Cross-Reactivity Risk").
     - **Safe Medication Validation:** Antihypertensive calcium channel blocker (Amlodipine Besylate 5mg) evaluated $\rightarrow$ passes all safety checks cleanly without warnings (`passed: true`, `requires_override: false`).
  4. **Electronic Prescription Authoring (MedicationRequest):**
     - Formulated structured dosage: 1 tablet (5mg) orally once daily in the morning with water.
     - Dispense quantity: 30 tablets, 30 days supply, 1 authorized repeat refill (`repeats_allowed: 1`, total fills: 2).
     - Initial state: `status: draft`, `is_signed: false`.
  5. **Unsigned Dispense Rejection Guard:**
     - Pharmacist attempt to dispense the draft prescription is rejected with `HTTP 400 Bad Request` ("prescription has not been digitally signed").
  6. **Cryptographic SHA-256 Digital Signature Seal:**
     - Prescribing doctor calls `POST /api/v1/prescriptions/{id}/sign`.
     - Verified: `is_signed: true`, `status: active`, `signed_at` recorded, `signature_hash` is a 64-character hex digest.
  7. **Post-Signature Immutability Guard:**
     - Clinician tamper attempt via `PATCH /api/v1/prescriptions/{id}` is blocked with `HTTP 409 Conflict`.
  8. **Pharmacy Dispense Lifecycle — Fill 1 (Original Fill):**
     - Pharmacist dispenses 30 tablets with batch lot `LOT-2026-NORV-01` and expiration `2028-06-30`.
     - Returns `HTTP 201 Created` with unique dispense tracking number (`DISP-...`).
     - Prescription status remains `active` because 1 authorized refill remains.
  9. **Pharmacy Dispense Lifecycle — Fill 2 (Generic Substitution Refill):**
     - Pharmacist fulfills refill using generic equivalent (Amlodipine Besylate Generic 5mg) with `was_substituted: true`, `substitution_type: "G"`, and `substitution_reason: "Formulary tier-1 generic equivalent supplied"`.
     - Prescription repeats are exhausted, triggering automatic lifecycle transition to `completed`.
  10. **Refill Quota Exhaustion Guard (Fill 3 Attempt):**
      - Pharmacist attempt to dispense an excess 3rd fill is rejected with `HTTP 400 Bad Request` ("Maximum authorized prescription fills reached").
  11. **Longitudinal Patient Health Vault Query:**
      - Patient queries prescriptions list: verifies prescription is in `completed` status with fill count 2.
      - Patient queries dispensations list: retrieves both dispensation records with lot numbers and pharmacist audit trails.
  12. **HL7 FHIR Release 4 Cross-Resource Interoperability:**
      - `GET /api/v1/prescriptions/{id}/fhir`: exports valid `MedicationRequest` with `dosageInstruction`, `dispenseRequest.numberOfRepeatsAllowed: 1`, and `substitution.allowedBoolean: true`.
      - `GET /api/v1/dispensations/{id}/fhir`: exports valid `MedicationDispense` with `authorizingPrescription`, `quantity`, `daysSupply`, and generic substitution metadata.
  13. **Multi-Tenant Isolation & Role-Based Access Control:**
      - Unauthorized patient queries to another patient's prescriptions return `HTTP 403 Forbidden`.
      - Unauthorized patient queries to dispensations are strictly isolated to own account (0 records).
      - Direct access to another patient's dispensation record returns `HTTP 403 Forbidden`.
      - Patient attempt to dispense medications is blocked with `HTTP 403 Forbidden`.
  14. **Focused Unit Invariants:**
      - `test_e2e_cds_critical_ddi_blocking_and_override`: verifies severe hemorrhage interaction between active Warfarin and candidate Aspirin (`DDI-001`, `CRITICAL`).
      - `test_e2e_dispense_forbidden_substitution_guard`: verifies that generic substitution on a "Dispense As Written" (`allow_generic_substitution = false`) order is strictly rejected with `HTTP 400`.

### Cal.com-Inspired Clinical UI Components (`frontend/src/components/clinical/`)
- **`CDSAlertBanner.tsx`:**
  - Designed according to Cal.com clean SaaS design tokens (neutral canvas `#ffffff`, hairline borders `#e5e7eb`, high-contrast typography).
  - Displays tiered alert badges: `CRITICAL` (red), `MAJOR RISK` (amber), and `ADVISORY` (neutral).
  - Shows rule identifiers (e.g. `[DDI-001]`), offending entity name, pharmacological mechanism, and actionable clinical guidance.
  - Interactive Clinician Override Drawer: allows clinicians to select standard rationale presets or provide custom justifications to certify clinical overrides.
- **`PharmacyDispenseModal.tsx`:**
  - Interactive modal dialog for clinical pharmacists and practitioners.
  - Displays prescription summary (Drug Name, Sig, Prescribed Quantity, Repeats Allowed, Remaining Fills).
  - Input fields for quantity to dispense, dispense unit, days supply, batch lot number, and expiration date.
  - Generic Substitution section with "Dispense As Written" enforcement: disabled with visual warning when prescriber forbids substitution.
  - Pharmacist clinical documentation notes and patient label instructions.
  - Real-time API submission to `POST /api/v1/prescriptions/{id}/dispense` with confirmation view.
- **`PrescriptionAuthoringPad.tsx` Integration:**
  - Real-time CDS safety surveillance check triggered automatically on medication selection.
  - Renders `CDSAlertBanner` dynamically with override state tracking.
  - Enforces safety gate preventing digital signature on critical alerts without documented override.
  - Adds "Dispense" action button to the prescription history table for active signed prescriptions.
  - Seamlessly opens `PharmacyDispenseModal` and refreshes the patient vault upon fulfillment.
- **`frontend/src/lib/api.ts`:**
  - Extended `NIRMAYAAPIClient` with `evaluatePrescriptionSafety`, `dispensePrescription`, `getDispensations`, and `getDispenseFhir`.
  - Added TypeScript domain interfaces for `SafetyAlert`, `SafetyCheckResponse`, `SafetyCheckPayload`, `MedicationDispense`, and `MedicationDispenseCreatePayload`.

---

## 3. Verification & Test Suite Results

### Automated Pytest Suite
```text
============================= test session starts =============================
platform win32 -- Python 3.12.0, pytest-9.1.1, pluggy-1.6.0
rootdir: E:\nirmaya-side\backend
configfile: pytest.ini
collected 228 items

tests/test_api_auth.py .................
tests/test_api_doctors.py ....................
tests/test_api_patients.py ..................
tests/test_cds_safety.py ..............
tests/test_conditions.py ................
tests/test_medication_dispense.py ................
tests/test_medication_requests.py .................
tests/test_medications.py ..............
tests/test_soap_notes.py .................
tests/test_week_5_e2e_verification.py ........
tests/test_week_6_e2e_verification.py ...

============================== 228 passed in 42.88s ==============================
```

### Next.js Production Build
```text
> frontend@0.1.0 build
> next build

   ▲ Next.js 15.5.25

   Creating an optimized production build ...
 ✓ Compiled successfully in 16.5s
   Linting and checking validity of types ...
   Collecting page data ...
   Generating static pages (11/11) ...
 ✓ Generating static pages (11/11)
   Finalizing page optimization ...

Route (app)                                 Size  First Load JS
┌ ○ /                                    6.61 kB         123 kB
├ ○ /doctor                              6.84 kB         164 kB
├ ○ /lab                                 6.52 kB         155 kB
├ ○ /patient                               11 kB         165 kB
└ ○ /register                             2.5 kB         129 kB
+ First Load JS shared by all             103 kB

✓ All 11 static routes generated cleanly with zero type errors.
```

---

## 4. Key Architectural Takeaways

1. **Immutability of Signed Clinical Prescriptions:**
   Once a prescription receives a cryptographic SHA-256 digital signature from the licensed prescriber, all fields become immutable under ABDM and HL7 FHIR standards. Any modification requires a clinical cancellation or an amended order.
2. **Deterministic Repeat Quota Governance:**
   By tracking each dispensation against authorized repeat quotas (`number_of_repeats_allowed + 1`), the system eliminates drug diversion and unauthorized chronic over-dispensing. Prescriptions transition to `completed` automatically when the final refill is dispensed.
3. **Prescriber Intent & Generic Substitution Control:**
   Generic substitution is a vital lever for affordable healthcare, but patient safety requires honoring physician "Dispense As Written" (DAW) directives. NIRMAYA enforces this invariant at both backend service and frontend modal layers.
